Hydrogen Water Intervention With Heart Rate Variability as an Outcome Biomarker in ME/CFS
Launched by STONY BROOK UNIVERSITY · Jun 3, 2025
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating whether hydrogen water, a supplement that can be bought over the counter, helps reduce fatigue and improve daily functioning in adults with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). The trial also aims to find out if a measurement called heart rate variability (HRV) can help predict which patients might benefit from drinking hydrogen water. The researchers are looking for participants aged between 18 and 75 who meet specific criteria for ME/CFS, and who do not have other medical conditions that could explain their fatigue.
If you choose to participate in this study, you will be helping to determine if hydrogen water is an effective treatment for ME/CFS symptoms. Participants will be recruited for the trial, and those who qualify will be asked to follow certain guidelines during the study period. This research is important because it could lead to new ways to help manage fatigue for people living with this challenging condition.
Gender
ALL
Eligibility criteria
- • Inclusion Criteria: Meets Institute of Medicine criteria for myalgic encephalomyelitis/chronic fatigue syndrome -
- • Exclusion Criteria: Medical illness that explains presenting fatigue; Any psychosis.
- • -
About Stony Brook University
Stony Brook University, a prominent research institution located in New York, is dedicated to advancing medical science through innovative clinical trials and research initiatives. As a sponsor, Stony Brook University leverages its extensive resources, interdisciplinary expertise, and state-of-the-art facilities to conduct rigorous clinical studies aimed at improving patient care and health outcomes. With a commitment to ethical standards and collaborative partnerships, the university fosters an environment conducive to groundbreaking discoveries and the translation of research findings into clinical practice.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Stony Brook, New York, United States
Patients applied
Trial Officials
Fred Friedberg, PhD
Principal Investigator
Stony Brook University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported